Company intelligence / Profile preview

SMCS

Somerset, Wisconsin, United States

Ownership: Private
Development stage: Other

Overview

SMC Ltd. provides end-to-end contract manufacturing services for medical devices and combination drug-device products. Its proprietary Bios autoinjector platform is being developed with biopharma partners to enable self-administration of complex therapies including those for rare genetic diseases. The company offers design, development, GMP manufacturing, assembly, packaging, and distribution services globally with a strong focus on patient-centric device innovation.

Therapeutic areas: Rare Diseases
Modalities: DeviceCombination product platforms for biologics and small molecules
Industry: Contract Manufacturing Organization

Partnerships

Commercial-stage biopharmaceutical companies specializing in rare genetic diseasesMultiple global pharma/biotech clients leveraging the Bios platform and other device technologies

Beyond the preview

Go deeper on SMCS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMCS.

Explore the full profile